IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,862 | -99.6% | 180,317 | +11.1% | 0.14% | +145.5% |
| Q2 2022 | $730,000 | -38.6% | 162,237 | -35.0% | 0.06% | -29.5% |
| Q1 2022 | $1,188,000 | +465.7% | 249,597 | +783.7% | 0.08% | +200.0% |
| Q4 2021 | $210,000 | +31.2% | 28,243 | 0.0% | 0.03% | +23.8% |
| Q3 2021 | $160,000 | -1.2% | 28,243 | +55.9% | 0.02% | -76.7% |
| Q1 2015 | $162,000 | -40.9% | 18,120 | -1.1% | 0.09% | -16.7% |
| Q1 2014 | $274,000 | – | 18,320 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |